These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 29603271)

  • 1. Totally minimally invasive esophagectomy after neoadjuvant chemoradiotherapy: Long-term oncologic outcomes.
    Lubbers M; van Det MJ; Kreuger MJ; Hoekstra R; Hendriksen EM; Vermeer M; Kouwenhoven EA
    J Surg Oncol; 2018 Mar; 117(4):651-658. PubMed ID: 29603271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
    Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
    Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid minimally invasive Ivor Lewis esophagectomy after neoadjuvant chemoradiation yields excellent long-term survival outcomes with minimal morbidity.
    Woodard GA; Crockard JC; Clary-Macy C; Zoon-Besselink CT; Jones K; Korn WM; Ko AH; Gottschalk AR; Rogers SJ; Jablons DM
    J Surg Oncol; 2016 Dec; 114(7):838-847. PubMed ID: 27569043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Short-term outcomes of robot-assisted minimally invasive esophagectomy for esophageal cancer].
    Tan Z; Zhang X; Wang X; Fu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Sep; 19(9):995-998. PubMed ID: 27680066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
    Wang H; Tang H; Fang Y; Tan L; Yin J; Shen Y; Zeng Z; Zhu J; Hou Y; Du M; Jiao J; Jiang H; Gong L; Li Z; Liu J; Xie D; Li W; Lian C; Zhao Q; Chen C; Zheng B; Liao Y; Li K; Li H; Wu H; Dai L; Chen KN
    JAMA Surg; 2021 May; 156(5):444-451. PubMed ID: 33729467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemoradiotherapy followed by esophagectomy does not increase morbidity in patients over 70.
    Blom RL; van Heijl M; Klinkenbijl JH; Bergman JJ; Wilmink JW; Richel DJ; Hulshof MC; Reitsma JB; Busch OR; van Berge Henegouwen MI
    Dis Esophagus; 2013 Jul; 26(5):510-6. PubMed ID: 22925313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of minimally invasive esophagectomy in esophageal cancer after neoadjuvant chemoradiotherapy.
    Warner S; Chang YH; Paripati H; Ross H; Ashman J; Harold K; Day R; Stucky CC; Rule W; Jaroszewski D
    Ann Thorac Surg; 2014 Feb; 97(2):439-45. PubMed ID: 24266955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
    Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
    BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients.
    Bosch DJ; Muijs CT; Mul VE; Beukema JC; Hospers GA; Burgerhof JG; Plukker JT
    Ann Surg Oncol; 2014 Feb; 21(2):605-11. PubMed ID: 24100962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensified Neoadjuvant Chemoradiotherapy for Patients with Potentially Resectable Esophageal Cancer: A Retrospective Cohort Study.
    Boers J; Joldersma A; van Dalsen AD; Wiegman EM; Schenk BE; de Graaf JC; Pierik EGJM; Timmer PR; de Groot JWB
    Ann Surg Oncol; 2020 May; 27(5):1520-1528. PubMed ID: 31828691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Techniques and short-term outcomes for total minimally invasive Ivor Lewis esophageal resection in distal esophageal and gastroesophageal junction cancers: pooled data from six European centers.
    Straatman J; van der Wielen N; Nieuwenhuijzen GA; Rosman C; Roig J; Scheepers JJ; Cuesta MA; Luyer MD; van Berge Henegouwen MI; van Workum F; Gisbertz SS; van der Peet DL
    Surg Endosc; 2017 Jan; 31(1):119-126. PubMed ID: 27129563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy.
    Koëter M; van der Sangen MJ; Hurkmans CW; Luyer MD; Rutten HJ; Nieuwenhuijzen GA
    Radiat Oncol; 2015 Mar; 10():59. PubMed ID: 25884226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safe Introduction of Minimally Invasive Esophagectomy at a Medium Volume Center.
    Linder G; Jestin C; Sundbom M; Hedberg J
    Scand J Surg; 2020 Jun; 109(2):121-126. PubMed ID: 30739555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative carboplatin and paclitaxel-based chemoradiotherapy for esophageal carcinoma: results of a modified CROSS regimen utilizing radiation doses greater than 41.4 Gy.
    Nabavizadeh N; Shukla R; Elliott DA; Mitin T; Vaccaro GM; Dolan JP; Maggiore RJ; Schipper PH; Hunter JG; Thomas CR; Holland JM
    Dis Esophagus; 2016 Aug; 29(6):614-20. PubMed ID: 26043837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Short-term efficacy and safety of the synchronous neoadjuvant chemoradiotherapy with paclitaxel plus carboplatin in stage III adenocarcinoma of esophagogastric junction].
    Ji Y; Peng T; Wang G; Zhang Y; Cao M; Gao Q; Li S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1019-1024. PubMed ID: 30269322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally invasive esophagectomy may contribute to long-term respiratory function after esophagectomy for esophageal cancer.
    Kosumi K; Yoshida N; Okadome K; Eto T; Kuroda D; Ohuchi M; Kiyozumi Y; Nakamura K; Izumi D; Tokunaga R; Harada K; Mima K; Sawayama H; Ishimoto T; Iwatsuki M; Baba Y; Miyamoto Y; Watanabe M; Baba H
    Dis Esophagus; 2018 Jun; 31(6):. PubMed ID: 29444214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally Invasive Salvage Operations for Esophageal Cancer after Definitive Chemoradiotherapy.
    Nakajima M; Kato H; Muroi H; Kikuchi M; Takahashi M; Yamaguchi S; Sasaki K; Ishikawa H; Sakurai H; Kuwano H
    Digestion; 2018; 97(1):64-69. PubMed ID: 29393232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally Invasive Esophagectomy: A New Era of Surgical Resection.
    Treitl D; Hurtado M; Ben-David K
    J Laparoendosc Adv Surg Tech A; 2016 Apr; 26(4):276-80. PubMed ID: 27046331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary experience with minimally invasive Ivor Lewis esophagectomy.
    Tapias LF; Morse CR
    Dis Esophagus; 2012 Jul; 25(5):449-55. PubMed ID: 21967644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.